Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000234216 | SCV000286257 | benign | Long QT syndrome | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000247727 | SCV000320132 | benign | Cardiovascular phenotype | 2015-09-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001705252 | SCV000729074 | likely benign | not provided | 2021-02-18 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25351510, 23396983) |
Genome- |
RCV002253309 | SCV002525062 | benign | Cardiac arrhythmia, ankyrin-B-related | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003977651 | SCV004786990 | benign | ANK2-related disorder | 2020-03-03 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |